WebMar 24, 2024 · All earnings call transcripts on DermTech, Inc. (DMTK) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides. WebApr 11, 2024 · DermTech, Inc. heeft een overeenkomst aangekondigd met een Blues Plan in North Carolina. Het contract, dat een aanvulling is op een gunstig dekkingsbeleid dat op 15 maart 2024 van kracht werd,... 13 april 2024
DermTech, Inc. (NASDAQ:DMTK) Q4 2024 Earnings Call Transcript
Web2 days ago · DermTech's total covered lives in the U.S. are approximately 126 million, which includes 68 million for Medicare/Medicare Advantage and 58 million for commercial and governmental payers.. About The DermTech Melanoma Test. DermTech originally marketed its foundational assay under the name Pigmented Lesion Assay (PLA). The … WebJun 30, 2024 · DermTech will host a conference call and webcast to discuss the second quarter financial results on Wednesday, August 4, 2024 at 1:30 p.m. Pacific time / 4:30 p.m. Eastern time. The conference call can be accessed live over the phone by dialing (844) 467-7114 for U.S. callers or (409) 231-2086 for international callers, using conference ID ... short steel cables
DermTech Reports Fourth-Quarter and Full-Year 2024 Financial …
WebMar 6, 2024 · Welcome to DermTech's Fourth Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. ... Q4 2024 Earnings Call Transcript. Published on March 6 ... WebApr 11, 2024 · DermTech, Inc. announced an agreement with a Blues plan in North Carolina. The contract, which is in addition to a favorable coverage policy that became effective March 15, 2024, enhances access to the foundational assay of the DermTech Melanoma Test (DMT) for the more than 3.8 million members of this plan. WebAug 8, 2024 · Second-Quarter 2024 Financial Results. Billable sample volume grew 56 percent from the second quarter of 2024 to approximately 18,320. Assay revenue was $4.1 million, up 43 percent from the second ... sap alternative chart of accounts